Impact of MSI-H/dMMR on clinicopathological characteristics and prognosis of patients with BRAF V600E-mutated resectable colorectal cancer

Impact of MSI-H/dMMR on clinicopathological characteristics and prognosis of patients with BRAF V600E-mutated resectable colorectal cancer

Saved in:

Bibliographic Details
Main Author:	LI Jun, LU Tingwei, FANG Xuqian
Format:	Article
Language:	English
Published:	Editorial Office of China Oncology 2024-11-01
Series:	Zhongguo aizheng zazhi
Subjects:	\|colorectal cancer\|braf v600e mutation\|mismatch repair deficiency\|microsatellite instability\|prognosis
Online Access:	http://www.china-oncology.com/fileup/1007-3639/PDF/1733904251636-978858262.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancer
by: Yupeng Jiang, et al.
Published: (2025-02-01)

The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies
by: Qingzhe Wang, et al.
Published: (2025-01-01)

Successful Neoadjuvant Therapy with Pembrolizumab Monotherapy for Advanced Ascending Colon Cancer
by: Chien-Tzu Huang*, et al.
Published: (2023-07-01)

Durable Clinical Benefit after Dual Checkpoint Inhibition and Single-agent Nivolumab Following Pembrolizumab Failure in Mismatch Repair-deficient Colon Cancer
by: Yat-Fung Chow, et al.
Published: (2023-10-01)

Frecuencia de la inmunosupresión de BRAF V600E en ameloblastomas: Un análisis multi-insituticional de 86 casos en América Latina
by: Lauren Frenzel Schuch, et al.
Published: (2024-12-01)

DMMR status and synchronous lesions predicts metachronous lesions after curative resection for rectal cancer
by: Xijie Chen, et al.
Published: (2025-01-01)

Frequent mutation of K-RAS in addition to BRAF V600E in Ameloblastoma – An immunohistochemical study
by: Aishwariya Mohanty, et al.
Published: (2024-06-01)

RATIONAL DRUG DESIGN OF POTENT V600E-BRAF KINASE INHIBITORS THROUGH MOLECULAR DOCKING SIMULATION
by: Bello Abdullahi Umar, et al.
Published: (2019-12-01)

BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center’s experience
by: S. S. McThenia, et al.
Published: (2025-01-01)

Primary mucoepidermoid carcinoma of the thyroid with concomitant MAML2 gene rearrangement and BRAF V600E mutation – A case report
by: Frederica Loghides, et al.
Published: (2024-03-01)

BRAF V600E-mutated lung adenocarcinoma with thyroid metastasis as the initial manifestation: a case report
by: Yufei Liu, et al.
Published: (2025-02-01)

Harnessing Machine Learning and Nomogram Models to Aid in Predicting Progression-Free Survival for Gastric Cancer Patients Post-Gastrectomy with Deficient Mismatch Repair(dMMR)
by: Yifan Li, et al.
Published: (2025-01-01)

Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
by: Arianna Marinello, MD, et al.
Published: (2025-03-01)

Novel therapy: Combined BRAF and MEK inhibitors for locally advanced BRAF V600L–Positive mucosal melanoma in hypopharynx
by: Sivakamavalli Jeyachandran
Published: (2024-06-01)

The Clinicopathological Characteristics and Prognoses of dMMR Gastric Adenocarcinoma Patients
by: Jie Wang, et al.
Published: (2021-01-01)

Case report: a rare case of diffusely metastatic BRAF V600E-mutated colorectal cancer with concomitant infiltration of the skin and parotid gland
by: Aristeidis E. Boukouris, et al.
Published: (2025-01-01)

Management of asynchronous multifocal adult glioblastoma with loss of BRAFV600E -mutant clonality: a case report
by: Hannah Haile, et al.
Published: (2025-01-01)

The prognostic and immunomodulatory role of the MMR system in patients with stomach adenocarcinoma
by: Zhihui Tian, et al.
Published: (2025-01-01)

Inter- and Intra-observer Reproducibility of Thyroid Fine Needle Aspiration Cytology: An investigation of Bethesda 2023 Using Immunohistochemical BRAFV600E Antibody
by: Erdogan Bahattin, et al.
Published: (2024-12-01)

Suppressing GDF15 enhances the chemotherapeutic effect of 5 FU on MSI-H CRC by regulating the ferroptosis pathway SLC7A11/GSH/GPX4
by: Zhi min Huang Fu, et al.
Published: (2024-12-01)

The Olive Oil Monophenolic Secoiridoid Ligstroside Aglycone Suppresses Melanoma Progression by Targeting the BRAF Signaling Pathway
by: Md Ashiq Mahmud, et al.
Published: (2025-01-01)

Diagnostic challenges in the diagnosis and treatment of ovarian cancer in Lynch syndrome
by: Agnieszka Protasiuk, et al.
Published: (2025-01-01)

Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer
by: Chiara Cremolini, et al.
Published: (2023-01-01)

Lynch syndrome screening in colorectal and endometrial cancers in Iceland
by: Katla R. Kluvers, et al.
Published: (2025-01-01)

Neoadjuvant immunotherapy for DNA mismatch repair proficient/microsatellite stable non-metastatic rectal cancer: a systematic review and meta-analysis
by: Huan Zhang, et al.
Published: (2025-01-01)

Melanoma genomics – will we go beyond BRAF in clinics?
by: Justyna Mirek, et al.
Published: (2024-09-01)

Loss of Lkb1 cooperates with BrafV600E and ultraviolet radiation, increasing melanoma multiplicity and neural‐like dedifferentiation
by: Kimberley McGrail, et al.
Published: (2025-02-01)

A Case of Tumour Twins: A Rare Presentation of Simultaneous Breast and Endometrial Malignancies
by: Sreenidhi Sreeram, et al.
Published: (2024-12-01)

Frequency and Molecular Characteristics of Mismatch Repair-deficient Status among Multiple Synchronous Colorectal Cancers
by: Kenichi Chikatani, et al.
Published: (2025-01-01)

Systemic therapy of skin metastatic melanoma with BRAF gene mutation
by: Yu. S. Shakh-Paronyants, et al.
Published: (2023-03-01)

Lynch Syndrome—Impact of the Type of Deficient Mismatch Repair Gene Mutation on Diagnosis, Clinical Presentation, Surveillance and Therapeutic Approaches
by: Tudor Razvan Grigorie, et al.
Published: (2025-01-01)

Clinical Use of Dostarlimab in Advanced Stage and Recurrent Endometrial Cancer: Patient Selection and Perspectives
by: Bujnak AC, et al.
Published: (2025-01-01)

Case report: Gastric langerhans cell histiocytosis with BRAF deletion mutation in a child that was misdiagnosed as lymphoma
by: Zhi Wan, et al.
Published: (2025-01-01)

A rare case of vision loss caused by leptomeningeal metastasis of lung adenocarcinoma: a case report and literature review
by: Zhihua Li, et al.
Published: (2025-02-01)

Cytomorphological traits of fine-needle aspirates of hyalinizing trabecular tumor of the thyroid gland: A brief report
by: Fei Wang, et al.
Published: (2023-07-01)

Global trends and emerging insights in BRAF and MEK inhibitor resistance in melanoma: a bibliometric analysis
by: Jianhao Bai, et al.
Published: (2025-01-01)

Medullary colonic carcinoma with microsatellite instability has lower survival compared with conventional colonic adenocarcinoma with microsatellite instability
by: Miguel A. Gómez-Álvarez, et al.
Published: (2016-12-01)

Intratumoral and peritumoral radiomics for forecasting microsatellite status in gastric cancer: a multicenter study
by: Yunzhou Xiao, et al.
Published: (2025-01-01)

Magnolol induces cell death through PI3K/Akt‐mediated epigenetic modifications boosting treatment of BRAF‐ and NRAS‐mutant melanoma
by: Abdullah Al Emran, et al.
Published: (2019-03-01)

Dihydrotanshinone I enhanced BRAF mutant melanoma treatment efficacy by inhibiting the STAT3/SOX2 signaling pathway
by: Xing Luo, et al.
Published: (2025-01-01)